Haplotype analysis of the CYP2J2 gene associated with myocardial infarction in a Chinese Han population

Cell Biochemistry and Function

Volumn 28, Issue 6, 2010, Pages 435-439

  Jie, Zeng ^a   Hong, Kong ^a   Jianhong, Tao ^a   Biao, Cheng ^a   Yongmei, Zhou ^a   Jingchuan, Lai ^a  

^a SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Case control study; CYP2J2; Haplotype; Myocardial infarction; Single nucleotide polymorphism

Indexed keywords

CYSTEINE; CYTOCHROME P450 2J2; GLYCINE;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC MARKER; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77956797357     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1661     Document Type: Article

References (34)

1. Halcox JP, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 6: 653-658.
2. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol 2004; 10: 1731-1737.
3. Capdevila JH, Falck JR, Harris RC. Cytochrome P450 and arachidonic acid bioactivation: Molecular and functional properties of the arachidonate monooxygenase. J Lipid Res 2000; 41: 163-181.
4. Wu S, Moomaw CR, Tomer KB, et al. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 1996; 271: 3460-3468.
5. Imig JD. Epoxygenase metabolites. Epithelial and vascular actions. Mol Biotechnol 2000; 16: 233-251.
6. Spiecker M, Darius H, Hankeln T, et al. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. Circulation 2004; 110: 2132-2136.
7. Lee CR, North KE, Molly S, et al. CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: The Atherosclerosis Risk in Communities (ARIC) study. Pharmacogenet Genomics 2007; 17: 349-358.
8. Liu PY, Li YH, Chao TH, et al. Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction. Atherosclerosis 2007; 195(1): 199-206.
9. Crawford DC, Nickerson DA. Definition and clinical importance of haplotypes. Annu Rev Med 2005; 56: 303-320.
10. Koch W, Hoppmann P, Pfeufer A, et al. Toll-like receptor 4 gene polymorphisms and myocardial infarction: No association in a Caucasian population. Eur Heart J 2006; 27: 2524-2529.
11. Ruiz-Narváez EA, Yang Y, Nakanishi Y, et al. APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica. J Lipid Res 2005; 46: 2605-2613.
12. Guidelines Subcommittee. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151-183.
13. Koch W, Hoppmann P, Pfeufer A, et al. Toll-like receptor 4 gene polymorphisms and myocardial infarction: No association in a Caucasian population. Eur Heart J 2006; 27: 2524-2529.
14. Kumamoto T, Kawai Y, Arakawa K, et al. Association of Gln222Arg polymorphism in the deoxyribonuclease I (DNase I) gene with myocardial infarction in Japanese patients. EurHeart J 2006; 27: 2081-2087.
15. Kiechl S, Lorenz E, Reindl M, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002; 347: 185-192.
16. World Health Organization Study Group. Diabetes mellitus. WHOTech Rep Ser 1985; 727: 1-104.
17. Kayama T, Soma M, Rahmutula D, et al. Isolation of the 50-flanking region of genes by thermal asymmetric interlaced polymerase chain reaction. Med Sci Monit 2001; 7: 345-349.
18. Sano M, Kuroi N, Nakayama T, et al. The association study of calcitonin-receptor-like receptor gene in essential hypertension. Am J Hypertens 2005; 18: 403-408.
19. Livak KJ, Marmaro J, Todd JA. Towards fully automated genome-wide polymorphism screening. Nat Genet 1995; 9: 341-342.
20. Li Z, Zhang Z, He Z, et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: Update of the SHEsis (http://analysis.bio-x.cn). Cell Res 2009; 19(4): 519-523.
21. Zeldin DC. Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 2001; 39: 36059-36062.
22. Spiecker M, Liao JK. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids. Arch Biochem Biophys 2005; 2: 413-420.
23. Yu Z, Xu F, Huse LM, et al. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res 2000; 11: 992-998.
24. Lee CR, North KE, Bray MS, et al. Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study. Hum Mol Genet 2006; 10: 1640-1649.
25. Zee RY, Cheng S, Erlich HA, et al. Genetic variants of arachidonate 5- lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: A nested case-control approach. Stroke 2006; 37: 2007-2011.
26. Marenberg ME, Risch N, Berkman LF, et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330: 1041-1046.
27. Sarecka B, Zak I, Krauze J. Synergistic effects of the polymorphisms in the PAI-1 and IL-6 genes with smoking in determining their associated risk with coronary artery disease. Clin Biochem 2008; 41(7-8): 467-473.
28. Zak I, Sarecka B, Krauze J. Synergistic effects between 561A>C and 98G>T polymorphisms of E-selectin gene and hypercholesterolemia in determining the susceptibility to coronary artery disease. Heart Vessels 2008; 23(4): 257-263.
29. Kostulas K, Huang WX, Crisby M, et al. An angiotensin-converting enzyme gene polymorphism suggests a genetic distinction between ischaemic stroke and carotid stenosis. Eur J Clin Invest 1999; 29: 478-483.
30. Markus HS, Ruigrok Y, Ali N, et al. Endothelial nitric oxide synthase exon 7 polymorphism, ischemic cerebrovascular disease, and carotid atheroma. Stroke 1998; 29: 1908-1911.
31. Couderc R, Mahieux F, Bailleul S, et al. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study. Stroke 1993; 24: 661-664. (Pubitemid 23134283)
32. Reuner KH, Ruf A, Grau A, et al. Prothrombin gene G20210!A transition is a risk factor for cerebral venous thrombosis. Stroke 1998; 29: 765-769.
33. Markus HS, Ali N, Swaminathan R, et al. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke 1997; 28: 1739-1743.
34. Morris RW, Kaplan NL. On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 2002; 23: 221-233.